Conference Coverage
Conference Coverage
Clopidogrel flunks platelet reactivity control test in TAVI
WASHINGTON – For platelet reactivity after TAVI, ticagrelor is more effective than clopidogrel.
Conference Coverage
Disproportionately low U.S. research funding targets gynecologic cancers
NEW ORLEANS – National Cancer Institute research funding for gynecologic cancers during 2007-2014 fell way short of several other cancer types.
Conference Coverage
OlympiAD: No statistically significant boost in OS with olaparib in HER2-negative mBC
CHICAGO – In the final analysis, median OS was 2.2 months longer for olaparib monotherapy versus physician’s choice of chemotherapy in patients...
Conference Coverage
KEYNOTE-054: Adjuvant pembrolizumab beat placebo in high-risk resected melanoma
CHICAGO – One-year rates of recurrence-free survival for adjuvant pembrolizumab and placebo were 75% and 61%, respectively, in a phase 3 trial of...
Conference Coverage
Nivolumab shows promise in early-stage resectable NSCLC
The majority of 20 patients with resectable NSCLC were alive and recurrence-free 1 year after surgery and nivolumab treatment.
Conference Coverage
Enhanced recovery led to fewer complications for major oncologic procedures
CHICAGO – A study has found that enhanced recovery protocols are safe and feasible in major abdominal operations beyond colorectal surgery.
Conference Coverage
High engraftment with new umbilical transplant technique
SALT LAKE CITY – Robust expansion could make many more umbilical cord blood units available for adult transplant.
Conference Coverage
Gene strong predictor of metastasis in melanoma
CHICAGO – Investigators have identified four genes that are overexpressed in primary melanoma, including one, CXCL1, that holds promise as a...
Conference Coverage
The ‘holy grail’ of thrombosis prevention
SAN DIEGO – One expert says it’s the ability to determine the risk of recurrence with or without continuation of anticoagulant treatment.
Conference Coverage
VIDEO: Indocyanine green finds more sentinel lymph nodes
NEW ORLEANS – Indocyanine green surpassed isosulfan blue for mapping sentinel lymph nodes in stage I endometrial or cervical cancer in pivotal...
Conference Coverage
Trastuzumab plus chemo shows efficacy for high HER2 endometrial cancer
NEW ORLEANS – Combining trastuzumab with carboplatin and paclitaxel led to substantial responses in uterine serous carcinoma with high HER2 levels...